CSPC Pharmaceutical Group Limited (OTCMKTS:CSPCY) Short Interest Down 31.1% in September

by · The Cerbat Gem

CSPC Pharmaceutical Group Limited (OTCMKTS:CSPCY – Get Free Report) was the target of a large decline in short interest during the month of September. As of September 30th, there was short interest totalling 6,200 shares, a decline of 31.1% from the September 15th total of 9,000 shares. Based on an average daily volume of 414,600 shares, the days-to-cover ratio is presently 0.0 days.

CSPC Pharmaceutical Group Trading Up 2.2 %

Shares of OTCMKTS:CSPCY traded up C$0.08 during trading on Friday, hitting C$3.65. The stock had a trading volume of 6,906 shares, compared to its average volume of 35,543. CSPC Pharmaceutical Group has a 12-month low of C$2.25 and a 12-month high of C$3.82. The stock has a 50-day simple moving average of C$2.76 and a two-hundred day simple moving average of C$3.04.

CSPC Pharmaceutical Group Increases Dividend

The firm also recently disclosed a dividend, which will be paid on Thursday, December 5th. Shareholders of record on Friday, November 1st will be paid a dividend of $0.0575 per share. This is a boost from CSPC Pharmaceutical Group’s previous dividend of $0.06. The ex-dividend date of this dividend is Friday, November 1st.

CSPC Pharmaceutical Group Company Profile

(Get Free Report)

CSPC Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical products in the People's Republic of China, other Asian regions, North America, Europe, and internationally. The company operates through Finished Drugs, Bulk Products, and Functional Food and Others segments.

Read More